Iodide

Iodide

SCHEMBL5146472

CCCCCCN1c2ccccc2N(C)C1c1ccccc1.I

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.41
CES1 P23141 2/20 0.39
CDC25A P30304 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
KCNH2 Q12809 1/20 0.38
ALDH1A1 P00352 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
PDF Q9HBH1 1/20 0.37
ALDH2 P05091 1/20 0.37
ALDH3A1 P30838 1/20 0.37
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL428093 0.76 GBA1 (0.50) CES1CDC25AKMT2ATP53MAPT
SCHEMBL28326128 0.75 ALDH1A1 (0.44) CDC25AKMT2AKDM4ELMNAKCNH2
SCHEMBL28979096 0.75 CDC25A (0.46) CES1CDC25AKMT2AKDM4ELMNA
SCHEMBL28979323 0.75 CDC25A (0.46) CES1CDC25AKMT2AKDM4ELMNA
SCHEMBL28979310 0.75 CDC25A (0.46) CES1CDC25AKMT2AKDM4ELMNA
SCHEMBL28979082 0.75 CDC25A (0.46) CES1CDC25AKMT2AKDM4ELMNA
SCHEMBL28283751 0.75 CDC25A (0.46) CES1CDC25AKMT2AKDM4ELMNA
SCHEMBL28497161 0.74 CDC25A (0.48) CES1CDC25AKDM4EALDH1A1ALDH2
SCHEMBL29403090 0.74 PDGFRB (0.64) PDGFRBKDM4ELMNAALDH1A1
SCHEMBL993337 0.74 PDGFRB (0.64) PDGFRBKDM4ELMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7273953-B2 Process for producing arylamine FUJIFILM FINECHEMICALS CO., LTD. (JP) 2007-09-25 US disclosed
US-20060069287-A1 Process for producing arylamine FUJIFILM FINECHEMICALS CO., LTD. (JP) 2006-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069287-A1 Process for producing arylamine TYR, AADAC, AOC2 PDGFRB 341/4885CES1 2515/4885CDC25A 2390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.